Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1516 participants.
Also called NCT00970489
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,516 participants
- Sponsor
- Registry
-
NCT00970489
-
- Other papers using this trial's data
- Fish Oil Supplementation Does Not Affect Cognitive Outcomes in Cardiac Surgery Patients in the Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA) Trial
- Fish Oil and Perioperative Bleeding
- Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial
- Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT00970489. Randomized; quadruple masking; primary purpose prevention. Start 2010-08 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2017-04-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation
- Acronym
- OPERA
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Omega -3 fatty acids
- Intervention (Drug)
- Placebo
- Lead sponsor
- Brigham and Women's Hospital
- Collaborator
- The OPERA Investigators
Record details
- Record id
cardio:ct-nct00970489- Content hash
728d4b0c052fa25d00e83eed5f39ba26207c65f619dc38078fdc51bf7630a7a7